OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Sabina Zurac, Cristian Vlădan, Octavian Dincă, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Sabina Zurac, Cristian Vlădan, Octavian Dincă, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Showing 12 citing articles:
A study on the side effects caused by the Pfizer/BioNTech COVID-19 vaccine: Focus on IgG antibodies and serological biomarkers
Kameran M. Ali, Ayad M. Ali, Peshnyar Muhammad Atta, et al.
Central European Journal of Immunology (2024) Vol. 49, Iss. 1, pp. 2-10
Open Access | Times Cited: 2
Kameran M. Ali, Ayad M. Ali, Peshnyar Muhammad Atta, et al.
Central European Journal of Immunology (2024) Vol. 49, Iss. 1, pp. 2-10
Open Access | Times Cited: 2
Assessment of the Humoral Immune Response Following COVID-19 Vaccination in Healthcare Workers: A One Year Longitudinal Study
Mihaela Chivu‐Economescu, Teodora Vremera, Simona Ruţă, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1526-1526
Open Access | Times Cited: 10
Mihaela Chivu‐Economescu, Teodora Vremera, Simona Ruţă, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1526-1526
Open Access | Times Cited: 10
Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination
Francisco J. Cimas, Javier Torres, Jesús Ontañón, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Francisco J. Cimas, Javier Torres, Jesús Ontañón, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus
Jakub Swadźba, Andrzej Panek, Paweł Wąsowicz, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 471-471
Open Access | Times Cited: 1
Jakub Swadźba, Andrzej Panek, Paweł Wąsowicz, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 471-471
Open Access | Times Cited: 1
IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
Lorena O. Fernandes-Siqueira, Bruna G. Sousa, Carlos E. Cleto, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 4, pp. 100121-100121
Open Access | Times Cited: 7
Lorena O. Fernandes-Siqueira, Bruna G. Sousa, Carlos E. Cleto, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 4, pp. 100121-100121
Open Access | Times Cited: 7
The Study on Side Effects Caused by Pfizer/BioNTech COVID-19 Vaccine: Focus on IgG Antibodies, and Serological Biomarkers
Ayad M. Ali, Peshnyar M.A. Rashid, Kamaran M.Ali, et al.
Research Square (Research Square) (2024)
Open Access
Ayad M. Ali, Peshnyar M.A. Rashid, Kamaran M.Ali, et al.
Research Square (Research Square) (2024)
Open Access
Long-term dynamics of natural, vaccine-induced, and hybrid immunity to SARS-CoV-2 in a university hospital in Colombia: A cohort study
Nohemí Caballero, Diana M. Monsalve, Yeny Acosta‐Ampudia, et al.
Research Square (Research Square) (2024)
Open Access
Nohemí Caballero, Diana M. Monsalve, Yeny Acosta‐Ampudia, et al.
Research Square (Research Square) (2024)
Open Access
Antibody Response against SARS-CoV-2 after mRNA Vaccine in a Cohort of Hospital Healthy Workers Followed for 17 Months
D Tripodi, Roberto Dominici, Davide Sacco, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 506-506
Open Access
D Tripodi, Roberto Dominici, Davide Sacco, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 506-506
Open Access
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review
Vilija Gurkšnienė, Tadas Alčauskas, Fausta Majauskaitė, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1419-1419
Open Access
Vilija Gurkšnienė, Tadas Alčauskas, Fausta Majauskaitė, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1419-1419
Open Access
Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study
Domenico Pascucci, Adriano Grossi, Alberto Lontano, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 25-25
Open Access | Times Cited: 3
Domenico Pascucci, Adriano Grossi, Alberto Lontano, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 25-25
Open Access | Times Cited: 3
The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
Jakub Swadźba, Tomasz Anyszek, Andrzej Panek, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 278-278
Open Access | Times Cited: 1
Jakub Swadźba, Tomasz Anyszek, Andrzej Panek, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 278-278
Open Access | Times Cited: 1
Mathematical modeling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination
Javier Torres, Jesús Ontañón, Carlos de Cabo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Javier Torres, Jesús Ontañón, Carlos de Cabo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
